THIRI T N OO
Allopathic & Osteopathic Physicians|Internal Medicine CLAREMONT, CA NPI 1619256617
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine CA Novo Nordisk AS All categories
General Payments — all program years on this page
$141.35
- Category: General Payments
- Program years: PY2018
- Record count: 7
- As of (CMS publication): 2026-01-23
Latest program year (PY2018): $141.35 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2018) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $141.35 | 7 |
By paying entity
Latest program year (PY2018) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $36.07 | 2 |
| Amgen Inc. | $26.29 | 1 |
| Lilly USA, LLC | $23.65 | 1 |
| GlaxoSmithKline, LLC. | $21.98 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.31 | 1 |
| SANOFI PASTEUR INC. | $16.05 | 1 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2018 | $141.35 | 7 |
Records — PY2018 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 559847087 | Lilly USA, LLC | $23.65 | 01/18/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 568535225 | Amgen Inc. | $26.29 | 02/22/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 588166139 | Novo Nordisk Inc | $17.49 | 01/12/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 588166141 | Novo Nordisk Inc | $18.58 | 03/16/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 589500561 | Takeda Pharmaceuticals U.S.A., Inc. | $17.31 | 03/01/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 595435285 | GlaxoSmithKline, LLC. | $21.98 | 07/11/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 602121345 | Sanofi Pasteur Inc. | $16.05 | 02/14/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2018_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.